From: Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma
# | Networks | Total | p-value | FDR | In Data | Gene names |
---|---|---|---|---|---|---|
1 | 195 | 3.776E-15 | 2.760E-13 | 21 | AKT3, GRB2, NF-kB, VEGF-A, EGFR, STAT3, c-Myc, Cyclin D, GSK3 alpha/beta, N-Ras, AKT(PKB), NF-kB p50/p50, AKT2, c-Raf-1, GSK3 beta, IRS-1, IGF-1 receptor, AKT1, Cyclin D1, NF-kB1 (p50), SMAD4 | |
2 | 128 | 3.972E-15 | 2.760E-13 | 18 | AKT3, GRB2, NF-kB, STAT3, c-Myc, Cyclin D, GSK3 alpha/beta, N-Ras, AKT(PKB), NF-kB p50/p50, AKT2, c-Raf-1, GSK3 beta, Elk-1, IRS-1, AKT1, Cyclin D1, NF-kB1 (p50) | |
3 | 136 | 1.868E-13 | 8.656E-12 | 17 | GRB2, SHIP, NF-kB, STAT3, c-Kit, c-Myc, Cyclin D, N-Ras, AKT(PKB), Bim, NF-kB p50/p50, c-Raf-1, K-RAS, FOXO3A, Elk-1, AKT1, Cyclin D1 | |
4 | 235 | 1.677E-11 | 5.215E-10 | 19 | GRB2, NF-kB, VEGF-A, NF-kB1 (p105), EGFR, STAT3, c-Myc, AKT(PKB), AKT2, c-Raf-1, Skp2/TrCP/FBXW, GSK3 beta, Cyclin D1, PTEN, mTOR, NF-kB1 (p50), SMAD4, FBXW7, HIF1A | |
5 | 154 | 1.876E-11 | 5.215E-10 | 16 | SIP1 (ZFHX1B), GRB2, NF-kB, EGFR, RUNX2, c-Kit, c-Myc, AKT(PKB), c-Raf-1, IRS-1, IGF-1 receptor, Cyclin D1, mTOR, SMAD4, HIF1A, CREB1 | |
6 | 75 | 4.616E-11 | 1.069E-09 | 12 | GRB2, NF-kB, EGFR, STAT3, c-Myc, N-Ras, AKT(PKB), c-Raf-1, K-RAS, Elk-1, IRS-1, PTEN | |
7 | Development_EMT_Regulation of epithelial-to-mesenchymal transition | 224 | 6.898E-11 | 1.254E-09 | 18 | SIP1 (ZFHX1B), GRB2, EGFR, TCF8, STAT3, EGR1, ROCK1, AKT(PKB), c-Raf-1, GSK3 beta, Elk-1, TNF-alpha, CTGF, PTEN, mTOR, SMAD4, HIF1A, CREB1 |
8 | 119 | 7.216E-11 | 1.254E-09 | 14 | AKT3, GRB2, NF-kB, STAT3, c-Myc, AKT(PKB), NF-kB p50/p50, AKT2, c-Raf-1, 14-3-3 zeta/delta, Elk-1, AKT1, NF-kB1 (p50), 14-3-3 | |
9 | 107 | 2.434E-10 | 3.760E-09 | 13 | GRB2, NF-kB, VEGF-A, STAT3, EGR1, GSK3 alpha/beta, AKT(PKB), AKT2, c-Raf-1, IRS-1, AMPK alpha subunit, HIF1A, CREB1 | |
10 | 134 | 3.626E-10 | 4.742E-09 | 14 | GRB2, HDAC5, MEF2C, NF-kB, GSK3 alpha/beta, AKT(PKB), TBX3, c-Raf-1, GSK3 beta, SMAD5, Hamartin, PTEN, SMAD4, HIF1A | |
11 | 160 | 3.752E-10 | 4.742E-09 | 15 | NF-kB, VEGF-A, EGFR, EGR1, c-Myc, Cyclin D, AKT(PKB), c-Raf-1, IRS-1, IGF-1 receptor, CTGF, mTOR, SMAD4, HIF1A, CREB1 | |
12 | 72 | 5.284E-10 | 6.120E-09 | 11 | GRB2, NF-kB, EGFR, STAT3, AKT(PKB), c-Raf-1, FOXO3A, GSK3 beta, IGF-1 receptor, mTOR, CREB1 | |
13 | 118 | 8.432E-10 | 9.015E-09 | 13 | ROCK, AKT3, NF-kB, NF-kB1 (p105), ROCK1, AKT(PKB), NF-kB p50/p50, AKT2, c-Raf-1, Elk-1, AKT1, TNF-alpha, NF-kB1 (p50) | |
14 | 91 | 6.908E-09 | 6.859E-08 | 11 | GRB2, EGFR, GSK3 alpha/beta, AKT(PKB), c-Raf-1, GSK3 beta, Elk-1, IRS-1, IGF-1 receptor, Cyclin D1, CREB1 | |
15 | 145 | 1.087E-08 | 1.007E-07 | 13 | AKT3, GRB2, MEF2C, NF-kB, EGR1, AKT(PKB), AKT2, c-Raf-1, 14-3-3 zeta/delta, Elk-1, AKT1, TNF-alpha, 14-3-3 | |
16 | 127 | 2.325E-08 | 1.968E-07 | 12 | AKT3, GRB2, EGFR, GSK3 alpha/beta, AKT(PKB), AKT2, c-Raf-1, GSK3 beta, IRS-1, Hamartin, AKT1, mTOR | |
17 | 216 | 2.407E-08 | 1.968E-07 | 15 | GRB2, VEGF-A, NF-kB1 (p105), EGFR, c-Myc, AKT(PKB), AKT2, c-Raf-1, GSK3 beta, IRS-1, HDAC4, IGF-1 receptor, Cyclin D1, NF-kB1 (p50), SMAD4 | |
18 | 253 | 2.929E-08 | 2.262E-07 | 16 | GRB2, VEGF-A, TCF8, EGR1, c-Myc, Sirtuin1, ROCK1, c-Raf-1, Skp2/TrCP/FBXW, GSK3 beta, SMAD5, AKT1, Cyclin D1, SMAD4, FBXW7, CREB1 | |
19 | 222 | 3.480E-08 | 2.546E-07 | 15 | GRB2, NF-kB, VEGF-A, EGFR, TCF8, STAT3, c-Myc, AKT(PKB), c-Raf-1, CTGF, SMAD4, HIF1A, IGFBP7/8, CREB1, VEGFR-1 | |
20 | 137 | 5.467E-08 | 3.800E-07 | 12 | GRB2, SHIP, NF-kB, EGR1, GSK3 alpha/beta, AKT(PKB), NF-kB p50/p50, c-Raf-1, Elk-1, PTEN, mTOR, NF-kB1 (p50) | |
21 | 88 | 6.433E-08 | 4.258E-07 | 10 | NF-kB, VEGF-A, AKT(PKB), NF-kB p50/p50, c-Raf-1, Elk-1, IRS-1, CaMK II alpha, TNF-alpha, CREB1 | |
22 | 91 | 8.902E-08 | 5.624E-07 | 10 | GRB2, STAT3, ARG1, c-Myc, AKT(PKB), c-Raf-1, Elk-1, IRS-1, NF-kB1 (p50), CREB1 | |
23 | 174 | 9.726E-08 | 5.669E-07 | 13 | ROCK, GRB2, NF-kB, NF-kB1 (p105), ROCK1, AKT(PKB), Bim, NF-kB p50/p50, c-Raf-1, Elk-1, AKT1, TNF-alpha, NF-kB1 (p50) | |
24 | 206 | 9.789E-08 | 5.669E-07 | 14 | AKT3, GRB2, EGFR, c-Myc, AKT(PKB), AKT2, DNMT1, c-Raf-1, Skp2/TrCP/FBXW, 14-3-3 zeta/delta, HDAC4, IGF-1 receptor, AKT1, 14-3-3 | |
25 | 124 | 1.804E-07 | 1.003E-06 | 11 | GRB2, MEF2C, EGFR, FOG2, Neurofibromin, AKT(PKB), TBX3, c-Raf-1, GSK3 beta, Versican, Hamartin | |
26 | 87 | 6.923E-07 | 3.701E-06 | 9 | NF-kB, STAT3, c-Myc, Cyclin D, AKT(PKB), NF-kB p50/p50, Cyclin D1, TNF-alpha, NF-kB1 (p50) | |
27 | 115 | 8.212E-07 | 4.228E-06 | 10 | GRB2, SHIP, NF-kB, AKT(PKB), Bim, c-Raf-1, GSK3 beta, Elk-1, IRS-1, PTEN | |
28 | 91 | 1.018E-06 | 5.054E-06 | 9 | RUNX2, c-Myc, AKT(PKB), YY1, AKT2, SMAD5, AKT1, SMAD4, CREB1 | |
29 | Apoptosis_Anti-Apoptosis mediated by external signals via PI3K/AKT | 233 | 2.791E-06 | 1.338E-05 | 13 | GRB2, NF-kB, VEGF-A, EGFR, AKT(PKB), Bim, NF-kB p50/p50, FOXO3A, IRS-1, IGF-1 receptor, TNF-alpha, NF-kB1 (p50), VEGFR-1 |
30 | 104 | 3.152E-06 | 1.461E-05 | 9 | GRB2, NF-kB, STAT3, AKT(PKB), NF-kB p50/p50, c-Raf-1, Elk-1, PTEN, NF-kB1 (p50) | |
31 | 221 | 9.263E-06 | 4.154E-05 | 12 | GRB2, VEGF-A, EGFR, STAT3, c-Kit, c-Myc, AKT(PKB), c-Raf-1, GSK3 beta, IGF-1 receptor, Cyclin D1, VEGFR-1 | |
32 | Cardiac development_Wnt_beta-catenin, Notch, VEGF, IP3 and integrin signaling | 151 | 9.785E-06 | 4.250E-05 | 10 | MEF2C, VEGF-A, GSK3 alpha/beta, TBX3, c-Raf-1, GSK3 beta, Versican, MEF2, PTEN, VEGFR-1 |
33 | 228 | 1.272E-05 | 5.358E-05 | 12 | GRB2, NF-kB, VEGF-A, EGFR, STAT3, c-Myc, AKT(PKB), c-Raf-1, CTGF, HIF1A, IGFBP7/8, VEGFR-1 | |
34 | 210 | 3.159E-05 | 1.292E-04 | 11 | NF-kB, STAT3, c-Kit, c-Myc, AKT(PKB), c-Raf-1, Elk-1, TNF-alpha, mTOR, HIF1A, CREB1 | |
35 | 184 | 5.446E-05 | 2.163E-04 | 10 | GRB2, KLF4, EGR1, Neurofibromin, c-Myc, Mxi1, c-Raf-1, Elk-1, IGF-1 receptor, Cyclin D1 | |
36 | 38 | 7.474E-05 | 2.886E-04 | 5 | GRB2, STAT3, c-Myc, AKT(PKB), c-Raf-1 | |
37 | Muscle contraction_Nitric oxide signaling in the cardiovascular system | 124 | 9.686E-05 | 3.639E-04 | 8 | MEF2C, VEGF-A, Sirtuin1, AKT(PKB), AMPK alpha 1 subunit, Elk-1, HIF1A, CREB1 |
38 | Apoptosis_Anti-Apoptosis mediated by external signals by Estrogen | 95 | 1.178E-04 | 4.309E-04 | 7 | GRB2, c-Myc, AKT(PKB), c-Raf-1, Elk-1, NF-kB1 (p50), CREB1 |
39 | Development_ERK5 in cell proliferation and neuronal survival | 24 | 1.597E-04 | 5.691E-04 | 4 | MEF2C, c-Myc, c-Raf-1, CREB1 |
40 | 210 | 1.643E-04 | 5.711E-04 | 10 | AKT3, GRB2, NF-kB, STAT3, AKT(PKB), AKT2, c-Raf-1, AKT1, TNF-alpha, mTOR | |
41 | 214 | 1.918E-04 | 6.280E-04 | 10 | ROCK, GRB2, Caveolin-2, c-Myc, ROCK1, AKT(PKB), c-Raf-1, GSK3 beta, Hamartin, Cyclin D1 | |
42 | 214 | 1.918E-04 | 6.280E-04 | 10 | GRB2, VEGF-A, EGFR, STAT3, c-Myc, c-Raf-1, GSK3 beta, IGF-1 receptor, AKT1, CREB1 | |
43 | 137 | 1.943E-04 | 6.280E-04 | 8 | GRB2, NF-kB, AKT(PKB), NF-kB p50/p50, c-Raf-1, Elk-1, TNF-alpha, NF-kB1 (p50) | |
44 | 215 | 1.992E-04 | 6.294E-04 | 10 | ROCK, GRB2, NF-kB, STAT3, ROCK1, AKT(PKB), NF-kB p50/p50, c-Raf-1, TNF-alpha, NF-kB1 (p50) | |
45 | 140 | 2.256E-04 | 6.967E-04 | 8 | GRB2, NF-kB, Cyclin D, NF-kB p50/p50, Cyclin D1, TNF-alpha, NF-kB1 (p50), CREB1 | |
46 | Apoptosis_Anti-Apoptosis mediated by external signals via MAPK and JAK/STAT | 179 | 2.375E-04 | 7.176E-04 | 9 | GRB2, STAT3, EGR1, c-Myc, Bim, c-Raf-1, Elk-1, TNF-alpha, CREB1 |
47 | 108 | 2.628E-04 | 7.606E-04 | 7 | ROCK, NF-kB, ROCK1, AKT(PKB), NF-kB p50/p50, TNF-alpha, NF-kB1 (p50) | |
48 | 77 | 2.727E-04 | 7.606E-04 | 6 | GRB2, VEGF-A, EGFR, c-Raf-1, AKT1, TNF-alpha | |
49 | 144 | 2.736E-04 | 7.606E-04 | 8 | GRB2, SHIP, NF-kB, AKT(PKB), Bim, c-Raf-1, TNF-alpha, SMAD4 | |
50 | 144 | 2.736E-04 | 7.606E-04 | 8 | HDAC5, MEF2C, VEGF-A, Sirtuin, Histone deacetylase class II, Sirtuin1, HDAC4, MEF2 | |
Info | Â | Â | Â | Â | Â | Â |
General | Â | Â | Â | Â | Â | |
Date | 21/07/2018 | Â | Â | Â | Â | Â |
Server | Â | Â | Â | Â | Â | |
Version | 6.35.69300 | Â | Â | Â | Â | Â |
Workflow Settings | Â | Â | Â | Â | Â | |
Type | Enrichment analysis | Â | Â | Â | Â | Â |
Signals | both | Â | Â | Â | Â | Â |
Active Data | Â | Â | Â | Â | Â | |
Name | Type | Size | Â | Â | Â | Â |
74_NetICS_mouse_data_hub_19_Jul_2018_genelist | General | 74 | Â | Â | Â | Â |